Previous 10 | Next 10 |
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The increasingly hot market for online video delivery is set to take another sharp ...
YAVNE, Israel, March 18, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company will release its financial results for the...
MediWound's (NASDAQ: MDWD ) CEO, Gal Cohen, has decided to step down from his position. He will end his term by the end of May. More news on: MediWound Ltd., Healthcare stocks news, Read more ...
Chief Executive Officer Gal Cohen stepping down Available for transition and ongoing strategic process support Chief Financial & Operations Officer Sharon Malka will be appointed CEO Chairmen of the Board Stephen T. Wills will serve as Active Chairman ...
Gainers: Luokung Technology (NASDAQ: LKCO ) +136% . UQM Technologies (NYSEMKT: UQM ) +46% . Staffing 360 Solutions (NASDAQ: STAF ) +24% . MYnd Analytics (NASDAQ: MYND ) +18% . Boxlight Corporation (NASDAQ: BOXL ) +15% . XTL Biopharmaceuticals (NASDAQ: XTLB ) +14% . M...
CORAL GABLES, FL / ACCESSWIRE / January 22, 2019 / The future of healthcare stocks , and the medical sector industry as a whole, depends on medical experts rising to the challenge to meet the demands and necessities of consumers looking for qualitative care options. With the rise of global ...
Staffing 360 Solutions (NASDAQ: STAF ) +50% on re-signing largest client to multi-year contract. More news on: Staffing 360 Solutions, Inc., UQM Technologies, Inc, Bio-Path Holdings, Inc., Stocks on the move, , Read more ...
Thinly traded micro cap MediWound (NASDAQ: MDWD ) is up 36% premarket on light volume in response to its announcement of positive results from a Phase 3 clinical trial, DETECT , evaluating NexoBrid in patients with deep partial thickness and full thickness thermal burns. Mor...
Met Primary and All Secondary Endpoints with Statistically Significant Results Compared with Control Group Conference call with MediWound management and U.S. key opinion leader begins today, January 22, 2019 at 10:00 a.m. Eastern time YAVNE, Israel, Jan. 22, 2019 (GLOBE NEWSWIRE) -...
NEW YORK, NY / ACCESSWIRE / January7, 2019 / Traders News Source, a leading independent equity researchand corporate access firm focused on small and mid-cap public companies isissuing a comprehensive report on MediWound Ltd. (NASDAQ: MDWD ), a fully-integrated biopharmaceutical company f...
News, Short Squeeze, Breakout and More Instantly...
YAVNE, Israel, Aug. 02, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announced that the Company will release its financial results for the second quarter ended June 30, 2024 on Wednesday, August 14, 20...
Research Published in THE LANCET's eClinicalMedicine EscharEx ® Outperforms Non-Surgical Standard of Care in Debridement and Promotion of Healthy Granulation Tissue YAVNE, Israel, July 29, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in ne...
Funds to be used for clinical development of EscharEx ® to treat diabetic foot ulcers (DFUs) Award advances MediWound’s DFU program and its future revenues four years ahead of original schedule YAVNE, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd....